forex signal system trading: The FDA could make a big decision as early as this summer

You are receiving this as a part of your subscription to The Startup Investor. To remove your email from this list, unsubscribe here.

BREAKING NEWS: Vaccine Is 94%
Effective in Clinical Trials
Dear Startup Investor,

Something incredible just happened...

This California-based biotech just released results for the first phase of their vaccine trial.

And here's what we discovered...

Their vaccine was 94% effective at providing immunity from COVID-19.

It's the first COVID-19 vaccine in the world known to be precisely this effective...

And now, the FDA could make a big decision as early as this summer.

They could ultimately green-light this vaccine for selective use...

Leading millions of doctors and other essential workers to get the earliest doses of this vaccine.

In total, as many as seven billion vaccine doses are expected to be required.

And if it all goes according to plan for this vaccine manufacturer...

That could mean a 3,000% gain for investors when all the dust settles.

With positive results, most of the heavy lifting is already done.

You don't want to miss what happens next to their share price.

Click here to watch this video before the market opens tomorrow.

Sincerely,

Bob Keppel
Publisher, The Startup Investor

Please do not reply to this email. It was sent from an unmonitored mailbox.

You are receiving this e-mail at phanphuongthanh89.822152@blogger.com, as part of your subscription to The Startup Investor. To remove your email from this list: unsubscribe here.

To cancel, or for any other questions or requests, please contact our Customer Service team:
Online
Phone: 866-310-1498 (North America) 410-501-5876 (International)
Mail: The Startup Investor | Attn: Member Services | 1125 N Charles Street | Baltimore, MD 21201
Our Customer Service team is available Monday ‑ Friday between 9:00 AM and 5:00 PM ET.

© 2020 Angels & Entrepreneurs. All Rights Reserved.
Nothing in this email should be considered personalized financial advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed as personalized financial advice.

We expressly forbid our writers from having a financial interest in any security recommended to our readers. All of our employees and agents must wait 24 hours after on-line publication or 72 hours after the mailing of printed-only publication prior to following an initial recommendation. Any investments recommended in this letter should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company.

Protected by copyright laws of the United States and international treaties. This Newsletter may only be used pursuant to the subscription agreement and any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of: Angels & Entrepreneurs. 1125 N Charles Street, Baltimore, MD 21201.

Website | Privacy Policy | Terms & Conditions

The FDA could make a big decision as early as this summer

No comments:

Post a Comment